Cann, the leading provider of low-dose cannabis social tonic beverages, endorsed by celebrities like Gwyneth Paltrow, Chelsea Handler, Rebel Wilson, and Darren Criss, recently expanded its portfolio to include a new festive option – the Cranberry Sage flavor.
Described as "the perfect mix of sweet, tart and just a touch festive," the new Cranberry Sage flavor launched just in time for the holiday season. The beverage boasts the company's signature 5 ingredients and contains 2 mg of THC and 4 mg of CBD, letting you slightly unwind without having to worry about having a hangover the following day.
Consumers over the age of 21 can get their hands on the new cannabis-infused beverage from Cann online and in select dispensaries throughout California, Rhode Island, and Nevada.
Cannabis Cranberry Sage Beverages
Cann Recently Launched the New Cranberry Sage Flavor
Trend Themes
1. Low-dose Cannabis Beverages - Cann's low-dose cannabis social tonic beverages represent an opportunity for companies to create their own low-dose cannabis-infused beverages with different flavor profiles.
2. Celebrity Endorsements - Cann's celebrity endorsements represent an opportunity for companies to partner with celebrities and leverage their influence to promote their cannabis-infused products.
3. Holiday Season Products - Cann's release of the new Cranberry Sage flavor just in time for the holiday season represents an opportunity for companies to create cannabis-infused products that are seasonal or holiday-related.
Industry Implications
1. Beverage - The cannabis-infused beverage industry is growing rapidly and offers a disruptive innovation opportunity for companies to enter the market with unique flavor profiles.
2. Celebrity Endorsement - The use of celebrity endorsements in the cannabis industry offers a disruptive innovation opportunity for companies to leverage the influence of celebrities to promote their products.
3. Cannabis Product - Cann's low-dose cannabis social tonic beverages represent a disruptive innovation opportunity for companies to create new cannabis products that provide a low-dose THC and CBD ratio for consumers.